IntelliProve secures €2.7M to build the health sensing layer for any camera

Ghent, 19 November 2026 - IntelliProve has announced €2.7 million in seed funding to bring its health sensing layer from virtual care to humanoid robots. Belgian VC Miles Ahead leads the round, with The White and Yellow Cross (Dutch: Wit-Gele Kruis), imec.istart and several business angels taking part. The fresh capital will support IntelliProve on its mission to build the health sensing layer for any camera: heart rate, HRV, breathing and blood pressure in a 30-second face scan, no cuff.

People pick up their phone or open their laptop many times a day. Until now, those devices could tell them nothing about their own health without a separate device such as a blood pressure cuff or a wearable. IntelliProve adds that layer. A user looks into the camera for 30 seconds and gets six scientifically validated biomarkers back: heart rate, HRV, respiratory rate, systolic and diastolic blood pressure, and resonant breathing. The partner keeps its own app and brand. And because the layer is software, it is not tied to one device: it works with a standard camera, in a smartphone or laptop today and in a humanoid robot next.

Founded in 2021, IntelliProve works with academic and healthcare partners including TU Delft, Ghent University Hospital and The White and Yellow Cross. Today, its ISO 27001-certified technology runs in virtual care, health insurance and wellbeing platforms in more than 50 countries.

The camera is already there. Now it can measure too.

Healthcare systems face ageing populations, staff shortages and growing demand for care. Measurements that need a dedicated device, physical contact and a trained person do not scale with that demand. The cameras people already have do.

Joeri Tulkens, co-founder and co-CEO of IntelliProve: Healthcare is at a tipping point. We believe the future of health monitoring is software-first, scalable and accessible to everyone.

“Healthcare is at a tipping point. We believe the future of health monitoring is software-first, scalable and accessible to everyone,” says Joeri Tulkens, co-founder and co-CEO of IntelliProve. “Our virtual care partners are not just experimenting with IntelliProve, they are building it into the core of their offering. Humanoid robots are next: they are becoming very good at understanding the world around them, and the next step is helping them understand the people within that world. This funding lets us make IntelliProve the health sensing layer for any camera, worldwide.”

Built so care can rely on it

The science behind it is called remote photoplethysmography, or rPPG. Every heartbeat pushes blood through the face and changes the colour of the skin very slightly: invisible to the eye, but measurable by a camera. From those tiny changes, and from the small movements of breathing, the software can read heart rate, HRV, breathing and blood pressure, without touching the person.

The principle sounds simple. In real life it is not: people move, the light changes and no two cameras are the same. Quality control, signal extraction and cuffless blood pressure measurement are the most challenging aspects of camera-based measurements, and precisely what IntelliProve has focused on with its in-house R&D. IntelliProve built each of these in-house, as three proprietary technologies: VitalMesh, TripleGate and PulseShape.

IntelliProve's R&D team has authored and co-authored several peer-reviewed research papers, and its models are tested and validated on more than 6 million data points. Now, IntelliProve is taking it further on two fronts: CE marking as a Class IIa medical device under the EU Medical Device Regulation, and bringing the same health sensing layer to new devices with a camera, starting with humanoid robots.

Virtual care: health data from the app people already use

Care providers, health insurers and wellbeing platforms put the face scan inside their own apps. Their users do a short self check-in at home, on their own smartphone or laptop, and see heart rate, HRV, breathing and blood pressure within seconds. No cuff, no wearable, no extra device to send out. When people measure themselves at home, the values are already there when the conversation starts. Time spent measuring becomes time spent caring.

From seeing humans to understanding them

Humanoid robots are moving from controlled industrial environments into homes and care facilities. They already use cameras to see and navigate, and can tell that a person is standing in front of them, but not how that person is doing. IntelliProve provides that missing layer: with those same cameras, a robot can offer the person it assists a 30-second scan of heart rate, breathing rate and blood pressure, without additional measurement hardware. The robot passes the values on; a person interprets them and decides what happens next. The ambition is not to replace human care, but to extend its reach where care capacity is limited. Robots are one example: the same layer is open to any device with a camera that faces a person, such as smart glasses and self-service kiosks.

“Opening our technology to new devices doesn't change the standards we set for the technology itself,” says Tanguy Sanglet, co-founder and CTO of IntelliProve. “We will keep investing heavily in research, scientific validation and high-quality data, and we want our layer certified in markets around the world. Whether the scan runs on a smartphone or on a humanoid robot, the bar stays the same: the best health sensing layer in the world.”

What the €2.7 million will do

The funding strengthens the health sensing layer on three fronts: technology, certification and reach.

Luc Burgelman, founder of Miles Ahead, about IntelliProve: It’s now ready to scale at large with a meaningful impact on millions of lives, and that’s why we are leading this round.

“IntelliProve has built its face scan technology with virtual care platforms in more than 50 countries,” says Luc Burgelman, founder of Miles Ahead. “The company has developed a unique technology with a clear focus on scientific validation and certification. It’s now ready to scale at large with a meaningful impact on millions of lives, and that’s why we are leading this round.”

About IntelliProve

IntelliProve, founded in 2021 and based in Ghent, Belgium, builds the health sensing layer for any camera. Its plug-in software measures six scientifically validated biomarkers, including heart rate, HRV, breathing and blood pressure, in a 30-second face scan with a standard camera, validated on more than 6 million data points. IntelliProve's software is CE marked, and the company is ISO/IEC 27001 certified and GDPR compliant. Virtual care, health insurance and wellbeing platforms use it in more than 50 countries, and IntelliProve is now bringing it to humanoid robots.

About Miles Ahead

Miles Ahead is a Belgian early-stage Venture Capital Fund, helping first-time founders of Deep Tech & AI startups grow faster by building and funding their business in an empowering environment. Miles Ahead Capital I was created by technology entrepreneurs, with the purpose to provide adequate funding as well as to bring the experience and support to new technology companies to develop their business on a global scale. The fund was launched at the end of 2022 and manages €30M in capital. Furthermore Miles Ahead has a rich network of advisors and entrepreneurs in residence to coach its portfolio companies in different areas of expertise and industries. Its name is inspired by the Miles Davis album. Just like great music, successful ventures are created through great individual talent and strong team chemistry.

About The White and Yellow Cross

The White and Yellow Cross (Dutch: Wit-Gele Kruis) represents the largest non-profit organization for home nursing in Flanders (Northern part of Belgium). The organization is composed of five autonomous provincial organizations with a covering Federation in Brussels. In 2025, The White and Yellow Cross took care of 129,091 patients. The care staff visited 55,529 patients per month on average. The White and Yellow Cross counts 6,611 employees.

About imec.istart

Imec.istart, imec’s business accelerator, is the first investor and supporting partner to scale your tech startup. The imec.istart program offers a broad range of services such as initial financial injection (100,000 up to 250,000 EUR pre-seed funding), personal coaching and mentoring, access to technology and working facilities, access to a broad (inter)national network of partners and investors and more. Since its launch in 2011, imec.istart helped more than 300 tech startups in diverse fields to develop into sustainable ventures. Imec.istart is ranked world's best university linked Business Accelerator by UBI Global.